Other languages TherapeuticsMD, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
2.22 ^USD	+4.23%		+3.74%	-1.33%

May. 10	TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 29	TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

TherapeuticsMD: Q1 Earnings Snapshot	May. 10
TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10
TherapeuticsMD Announces First Quarter 2024 Financial Results	May. 10
TherapeuticsMD Announces Full Year 2023 Financial Results	Apr. 01
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29
TherapeuticsMD Announces Full Year 2023 Financial Results	Mar. 29
Knight Therapeutics Announces Launch of Bijuva in Canada	Feb. 06
Knight Therapeutics Announces Product Launch For IMVEXXY In Canada	Jan. 04
North American Morning Briefing : Stocks Seen Building on CPI Rally; PPI Data Due	Nov. 15
TherapeuticsMD: Q3 Earnings Snapshot	Nov. 15
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
TherapeuticsMD Announces Third Quarter 2023 Financial Results	Nov. 14
TherapeuticsMD, Inc. Announces Evaluation of Strategic Alternatives	Nov. 13
TherapeuticsMD, Inc. Announces Executive Changes	23-08-18
TherapeuticsMD: Q2 Earnings Snapshot	23-08-14
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
TherapeuticsMD Announces Second Quarter 2023 Financial Results	23-08-14
North American Morning Briefing : Stock Futures -2-	23-08-14
TherapeuticsMD : Change in Certifying Accountants - Form 8-K	23-07-10
TherapeuticsMD, Inc. announced that it has received $1.149998 million in funding from Rubric Capital Management LP	23-06-28

No results for this search